Interim Results for the period ended 31st December 2018

Interim Results for the period ended 31st December 2018

Oxford, UK, 21 February 2019: The Board of Physiomics Plc, a provider of technology- based solutions to predict the effects of cancer treatment regimens for the biopharma industry (AIM: PYC), today announces its financial results for the six months ended 31 December 2018.

Click here to read in full.